PE20000267A1 - Derivados de ciclohexanodiol - Google Patents

Derivados de ciclohexanodiol

Info

Publication number
PE20000267A1
PE20000267A1 PE1999000151A PE00015199A PE20000267A1 PE 20000267 A1 PE20000267 A1 PE 20000267A1 PE 1999000151 A PE1999000151 A PE 1999000151A PE 00015199 A PE00015199 A PE 00015199A PE 20000267 A1 PE20000267 A1 PE 20000267A1
Authority
PE
Peru
Prior art keywords
keratinization disorders
dodeca
trifluoro
diol
trifluoromethyl
Prior art date
Application number
PE1999000151A
Other languages
English (en)
Inventor
Pierre Barbier
Peter Mohr
Franz Bauer
Marc Muller
Wolfgang Pirson
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20000267A1 publication Critical patent/PE20000267A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/08—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/292—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with chromium derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/02—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen
    • C07C47/19—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/26—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing hydroxy groups
    • C07C47/263—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing hydroxy groups acyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/26—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing hydroxy groups
    • C07C47/273—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing hydroxy groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Abstract

SE REFIERE A DERIVADOS DE RETIFEROL DE FORMULA I DONDE: X ES C=CH2 o CH2; "Y" Y "Z" SON H, F, HIDROXI; A ES -C­C-, -CH=CH-, -CH2-CH2-; R1 Y R2 SON ALQUILO, PERFLUOROALQUILO; R3 ES ALQUILO. SON COMPUESTOS PREFERIDOS (1R,3R)-5-[(2E,9Z)-12,12,12-TRIFLUORO-11-HIDROXI-7,7-DIMETIL-11-TRIFLUOROMETIL-DODECA-2,9-DIENILENO]-CICLOHEXANO-1,3-DIOL; (Z)-(1R,3S)-4-METILENO-5-[(2E,9Z)-12,12,12-TRIFLUORO-11-HIDROXI-7,7-DIMETIL-11-TRIFLUOROMETIL-DODECA-2,9-DIENILIDENO]-CICLOHEXANO-1,3-DIOL, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I ES UN POTENTE ACTIVADOR DEL RECEPTOR DE VITAMINA D (VDR) Y PUEDE SER UTIL PARA EL TRATAMIENTO DE ENFERMEDADES HIPERPROLIFERATIVAS DE LA PIEL TAL COMO PSORIASIS, CARCINOMAS DE CELULAS BASALES, TRASTORNOS DE LA QUERATINIZACION Y QUERATOSIS, ENFERMEDADES NEOPLASICAS, TRASTORNOS DE LAS GLANDULAS SEBACEAS (ACNE, DERMATITIS SEBORREICA) O PARA EL TRATAMIENTO ORAL O TOPICO DE LA PIEL DANADA POR EXPOSICION AL SOL, LOS EFECTOS DE LA APARICION DE ARRUGAS, ELASTOSIS Y ENVEJECIMIENTO PREMATURO
PE1999000151A 1998-02-26 1999-02-22 Derivados de ciclohexanodiol PE20000267A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98103346 1998-02-26

Publications (1)

Publication Number Publication Date
PE20000267A1 true PE20000267A1 (es) 2000-04-10

Family

ID=8231480

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000151A PE20000267A1 (es) 1998-02-26 1999-02-22 Derivados de ciclohexanodiol

Country Status (21)

Country Link
US (1) US6184422B1 (es)
EP (1) EP1056716B1 (es)
JP (1) JP3507435B2 (es)
KR (1) KR20010041313A (es)
CN (1) CN1133621C (es)
AR (1) AR018120A1 (es)
AT (1) ATE229503T1 (es)
AU (1) AU751241B2 (es)
BR (1) BR9908315A (es)
CA (1) CA2320180C (es)
CO (1) CO4980898A1 (es)
DE (1) DE69904442T2 (es)
DK (1) DK1056716T3 (es)
ES (1) ES2188134T3 (es)
MA (1) MA26609A1 (es)
MY (1) MY133520A (es)
PE (1) PE20000267A1 (es)
PT (1) PT1056716E (es)
TR (1) TR200002477T2 (es)
WO (1) WO1999043646A1 (es)
ZA (1) ZA991550B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0009520A (pt) * 1999-04-01 2002-06-11 Esperion Therapeutics Inc Composto, método para sintetizar o mesmo, composição, metódos para o tratramento ou prevenção, em um paciente, de doença cardiovascular, dislipidemia, dislipoproteinemia, distúrbio de metabolismo de glucose, doença de alzheimer, sìndrome x ou sìndrome metabólica, septicemia, distúrbio trombótico, distúrbio associado com receptor ativado por proliferador de peroxissoma, obesidade, pancreatite, hipertensão, doença renal, câncer, inflamação, impotência, para reduzir o teor de gordura de carne de gado bovino, e, para reduzir o teor de colesterol de ovos de aves
EP1094060B1 (en) * 1999-10-18 2004-04-28 Basilea Pharmaceutica AG New process for the preparation of retiferol derivatives
US6310262B1 (en) 1999-10-18 2001-10-30 Basilea Pharmaceutica Ag Process for preparing retiferol derivatives
WO2002042247A1 (en) * 2000-11-22 2002-05-30 F.Hoffmann-La Roche Ag Retiferol derivatives and their use in the treatment of skin diseases or conditions associated with photodamage
ATE420855T1 (de) * 2001-12-26 2009-01-15 Hiroaki Takayama 2-substituierte vitamin-d-derivate
US6723755B2 (en) 2002-06-12 2004-04-20 Piotr Chomczynski Method of treating rosacea
US7812057B2 (en) * 2004-08-25 2010-10-12 Molecular Research Center, Inc. Cosmetic compositions
ES2533719T3 (es) * 2005-08-30 2015-04-14 Wisconsin Alumni Research Foundation Análogos Des-C,D de 1alfa,25-dihidroxi-19-norvitamina D3
GB0712653D0 (en) 2007-06-28 2007-08-08 Syngenta Ltd Novel herbicides
CA2712748A1 (en) * 2008-01-22 2009-07-30 Wisconsin Alumni Reasearch Foundation 13,13-dimethyl-des-c,d analogs of 1.alpha.,25-dihydroxy-19-nor-vitamin d3 compounds and topical composition dosage forms and methods of treating skin conditions thereof
KR20170096238A (ko) * 2009-01-27 2017-08-23 베르그 엘엘씨 화학요법과 연관된 부작용을 경감시키기 위한 비타민 ｄ３ 및 이의 유사물
JP5978130B2 (ja) 2009-08-14 2016-08-24 バーグ エルエルシー 脱毛症を治療するためのビタミンｄ３およびその類似体
EP3003497B1 (en) 2013-05-29 2024-02-14 BPGbio, Inc. Preventing or mitigating chemotherapy induced alopecia using vitamin d
CN114044788A (zh) * 2021-08-12 2022-02-15 甘肃皓天医药科技有限责任公司 一种氟骨化醇cd环的制备方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2166898C (en) 1993-07-09 2004-09-07 Roger Bouillon Novel structural analogues of vitamin d
PL174912B1 (pl) 1994-01-24 1998-10-30 Inst Farmaceutyczny Nowe związki farmakologicznie czynne z grupy witamin D i sposób ich otrzymywania
US5461116A (en) 1994-11-10 1995-10-24 Shell Oil Company Core functionalized star block copolymers
EP0983221B1 (en) * 1997-05-23 2002-04-03 Basilea Pharmaceutica AG Cyclohexanediol derivatives

Also Published As

Publication number Publication date
AU2624699A (en) 1999-09-15
CA2320180A1 (en) 1999-09-02
EP1056716A1 (en) 2000-12-06
ATE229503T1 (de) 2002-12-15
CO4980898A1 (es) 2000-11-27
TR200002477T2 (tr) 2001-03-21
DE69904442D1 (en) 2003-01-23
US6184422B1 (en) 2001-02-06
PT1056716E (pt) 2003-04-30
JP2002504537A (ja) 2002-02-12
CN1133621C (zh) 2004-01-07
DK1056716T3 (da) 2003-04-07
CN1291974A (zh) 2001-04-18
CA2320180C (en) 2005-06-07
BR9908315A (pt) 2000-11-07
MA26609A1 (fr) 2004-12-20
AR018120A1 (es) 2001-10-31
KR20010041313A (ko) 2001-05-15
EP1056716B1 (en) 2002-12-11
MY133520A (en) 2007-11-30
ZA991550B (en) 1999-08-26
ES2188134T3 (es) 2003-06-16
JP3507435B2 (ja) 2004-03-15
WO1999043646A1 (en) 1999-09-02
DE69904442T2 (de) 2003-09-25
AU751241B2 (en) 2002-08-08

Similar Documents

Publication Publication Date Title
PE20000267A1 (es) Derivados de ciclohexanodiol
RU2005134130A (ru) Трипептиды и их производные для косметического применения для улучшения структуры кожи
ES2134207T3 (es) Procedimiento de preparacion y de utilizacion de la vitamina 1alfa,24-dihidroxi vitamina d2.
PE120899A1 (es) Derivados de d-homo-9,10-seco-colesta-23-in-3,25-diol
DK0654467T3 (da) Vitamin D3-analoger
CN1269786A (zh) 用作fp激活剂的芳香族c16－c20－取代四氢前列腺素
BRPI0410369A (pt) composições compreendendo uma amidina e um alcano poliol
ES2184686T3 (es) Composicion que comprende un compuesto derivado de ciclohexano, compuesto y utilizacion de dicho compuesto para estructurar una composicion.
US4931471A (en) Amides of paramethoxycinnamic and utilization thereof as solar filters
BR9916440A (pt) Composição tópica, processo cosmético para clareamento de pele humana, e, uso do ácido linoleico conjugado e/ou derivados do mesmo
ES2091515T3 (es) Analogos fluorados de la vitamina d3.
JPH03115270A (ja) 新規ピリミジン―３―オキシドハロゲン化誘導体および脱毛治療／予防剤組成物
DE60316882D1 (de) Photokatalytisches Bleichmittel für Zähne und Methode
ATE181062T1 (de) 1alpha,24(s)-dihydroxy vitamin d2, seine synthese und verwendung
ES2140765T3 (es) Guanididas sustituidas del acido cinamico, procedimiento para su preparacion, su uso como medicamento o agente de diagnostico cardiovascular, asi como medicamento que las contiene.
LU87304A1 (fr) Nouveaux derives d'ureylene triamino-2,4,6 pyrimidine oxyde-3,leur preparation et leur utilisation en cosmetique et dermopharmacie
ES2039719T3 (es) Procedimiento para preparar un agente terapeutico para el tratamiento de la enfermedad de ulcera peptica.
AR012852A1 (es) Un compuesto derivado de ciclohexanodiol, su uso, un procedimiento para prepararlo, compuestos utiles como intermediarios para preparar a dichocompuesto y una composicion farmaceutica que comprende a dicho compuesto
AR006315A1 (es) Derivados de 1,25 dihidroxi-16,22,23-trisdehidro-colecalciferol, compuestos intermediarios para su exclusivo uso en el procedimiento de obtencion de dichoscompuestos, composicion farmaceutica que los contiene, procedimiento de preparación de dichos derivados y empleo de dichos derivados para preparar
ATE229937T1 (de) Vitamin d 3? derivate und verfahren zur herstellung derselben
ECSP972061A (es) Derivados de 1,25 -dihidroxi-16, 22, 23-trien - colecalciferol
HUT50628A (en) Process for producing pharmaceutical compositions comprising retinoid
FR2377153A1 (fr) Agent de regulation du metabolisme des plantes, contenant comme substance active des esters d'acide sulfoniques
ECSP992868A (es) Derivados de ciclohexanodiol
JPS61289017A (ja) 皮膚化粧料

Legal Events

Date Code Title Description
FC Refusal